Exemptia Inj 40

Exemptia 40 – Adalimumab

Exemptia 40, also known by its generic name Adalimumab, is a monoclonal antibody used in the treatment of various autoimmune diseases. It works by inhibiting tumor necrosis factor-alpha (TNF-alpha), a substance in the body that causes inflammation.

Salt Composition:

• Adalimumab (40 mg/0.8 ml)

Key Features:

• Targeted Therapy: Specifically targets and neutralizes TNF-alpha to reduce inflammation.
• Wide Range of Uses: Effective for conditions such as rheumatoid arthritis, Crohn’s disease, and psoriasis.
• Subcutaneous Injection: Administered via injection for convenient home use.

American Brand Names:

• Humira

Indian Brand Names:

• Exemptia 40

Related Keywords:

Exemptia 40, Adalimumab, Humira, autoimmune treatment, TNF-alpha inhibitor, rheumatoid arthritis, Crohn’s disease, psoriasis, monoclonal antibody.